https://www.selleckchem.com/pr....oducts/Amprenavir-(A
LEVEL OF EVIDENCE NA Laryngoscope, 2021.In the era of coronavirus disease 2019 (COVID-19), the management of cardiac implantable electronic devices infections with concomitant viral infection has not been completely defined yet. In this explorable context, we report the first experience of a Cardiac resynchronization therapy with defibrillator (CRT-D) implantation after transvenous lead extraction for endocarditis in a COVID-19 patient. We describe both the measures and procedures implemented to reduce the cross-infection
Like
Comment
Share
